Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 49

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 49
---
issued share into one share.
On February 27, 2025, the Company received a notification letter from Nasdaq, indicating that the closing bid price of the Company’s
securities had been at $1.00 per share or greater for 10 consecutive business days from February 11, 2025 to February 26, 2025, and the
Company had regained compliance with the Minimum Bid Price Rule. Notwithstanding the foregoing, if within one year of the First Reverse
Stock Split or the Second Reverse Stock Split, the Company’s Class A Ordinary Shares fall below $1.00 per share for 30 consecutive
business days, or if within a two-year period from the First Reverse Stock Split or the Second Reverse Stock Split, the Company effects
one or more reverse stock splits with a cumulative ratio of 250 shares or more to one, then Nasdaq may not provide us with an additional
compliance period under its amended Listing Rule 5810(c)(3)(A)(iv) and our common stock could be delisted immediately.

On May 24, 2024, the Company
received a MVLS Deficiency Letter from the Listing Qualifications Department (the “Staff”) of Nasdaq notifying the Company
that, for the preceding 35 consecutive business days, the Class A Shares did not meet the minimum MVLS Requirement for continued listing
on Nasdaq pursuant to Nasdaq Listing Rules 5450(b)(2)(A). In accordance with Nasdaq Rule 5810(c)(3)(C), the Company has been provided
an initial period of 180 calendar days, or until November 20, 2024, the Compliance Date, to regain compliance with the MVLS Requirement.
If, at any time before the Compliance Date, the MVLS for the Class A Shares is at least $50,000,000 for a minimum of ten consecutive
business days, the Staff will provide the Company written confirmation of compliance with the MVLS Requirement. In the event the Company
does not regain compliance with the above requirement prior to the expiration of the compliance period, it will receive written notification
that its securities are subject to delisting.

On May 24, 2024, the Company
received a MVPHS Deficiency Letter from the Staff of Nasdaq notifying the Company that, for the preceding 35 consecutive business days,
the Company’s Class A Ordinary Shares did not meet the minimum $15,000,000 MVPHS Requirement for continued listing on Nasdaq pursuant
to